产品名称 | NebuSelect™ Recombinant SARS-COV-2 NSP7&NSP8, His-tag |
---|---|
目录号 | NBL-240624 |
别名 | NSP7&NSP8; SP7&NSP8; nsp7&nsp8 |
外观 | see COA |
分子量 | Ser1-Gln83(NSP7) & Ala1-Gln198(NSP8) |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | YP_009725303.1(NSP7)&YP_009725304.1(NSP8) |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240624-100ug | 100ug | Inquire | Inquire | |
NBL-240624-1mg | 1mg | Inquire | Inquire | |
NBL-240624-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant SARS-COV-2 NSP7&NSP8, His-tag
Catalog#:
NBL-240624
Description:
NebuSelect™ Recombinant SARS-COV-2 NSP7&NSP8, His-tag(Cat#NBL-240624) is expressed in E.coil with His tag at the C-Terminus.It contains Ser1-Gln83(NSP7)&Ala1-Gln198(NSP8).
Species:
SARS-CoV-2
Expression System:
E.coli
Molecular Weight:
The protein has a predicted MW of 32.8 kDa same as Bis-Tris PAGE result.
Target Name:
NSP7&NSP8; SP7&NSP8; nsp7&nsp8
Target Information:
The crystal structure of the metabolite of remdesivir (Monophosphate of GS-441524) and NSP12-NSP8-NSP7 of SARS CoV-2 virus was recently reported. The crystal structures of ADP-Ribose or AMP and NSP3 of SARS CoV-2 virus were also released, recently. The crystal structure of NSP3 of SARS CoV-2 virus as an alternative binding site of AMP or ADP-ribose to treat COVID-19.
Amino Acid Sequence:
Ser1-Gln83(NSP7) & Ala1-Gln198(NSP8)
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.